7-9 November 2016: BIO-Europe

The 11th edition of NLSDays is being held in Malmö on September 18-19. Program Director, Marjo Puumalainen, gives us an inside look into the upcoming conference.

Evaxion Biotech has announced new clinical phase 2 data for its lead compound EVX-01.

Lund University is establishing a university-wide development center for advanced therapies, LU-ATMP. Advanced Therapy Medicinal Products (ATMP) are medicines that are based on cells, tissues or genes. With ATMP, injuries and illnesses can be treated in completely new ways and provide better opportunities to relieve and, to a progressively greater extent, cure a wide range […]

A Finnish-led international research team has discovered novel gene variants that increase the risk of a rare but severe lung disease, idiopathic pulmonary fibrosis. The results also demonstrate notable genetic similarities with susceptibility to severe COVID-19 infection, reports HiLIFE. The study, led by the University of Helsinki, identified seven previously novel genetic risk factors. Only […]

An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Authority, and the team, led from Lund University is thereby ready to proceed with the trial, they state. […]

The grand opening of Health Proof Helsinki was held on 5 October 2022 at the Myllypuro campus of Metropolia University of Applied Sciences in Helsinki. Health Proof Helsinki is a a new health sector test environment ecosystem for research, development and innovation (RDI) providing companies with a service chain from early product development towards clinical […]

Genomic Medicine Sweden, GMS, has entered into an agreement with the Swedish life science sector’s trade associations to promote industry collaboration. The aim is to jointly strengthen national conditions for precision medicine. “For GMS, this agreement is a step towards creating improved and strengthened conditions for collaboration with industry. Through structured work, we will become […]